1. Home
  2. WST vs GFS Comparison

WST vs GFS Comparison

Compare WST & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$280.93

Market Cap

20.2B

Sector

Health Care

ML Signal

HOLD

Logo GlobalFoundries Inc.

GFS

GlobalFoundries Inc.

HOLD

Current Price

$39.10

Market Cap

18.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
GFS
Founded
1923
2009
Country
United States
United States
Employees
10600
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
20.2B
18.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WST
GFS
Price
$280.93
$39.10
Analyst Decision
Strong Buy
Buy
Analyst Count
10
10
Target Price
$346.78
$40.80
AVG Volume (30 Days)
661.6K
3.0M
Earning Date
10-23-2025
11-12-2025
Dividend Yield
0.31%
N/A
EPS Growth
0.17
N/A
EPS
6.75
N/A
Revenue
$3,017,900,000.00
$6,791,000,000.00
Revenue This Year
$7.01
$1.13
Revenue Next Year
$6.20
$6.42
P/E Ratio
$41.51
N/A
Revenue Growth
4.92
0.25
52 Week Low
$187.43
$29.77
52 Week High
$348.90
$47.69

Technical Indicators

Market Signals
Indicator
WST
GFS
Relative Strength Index (RSI) 55.28 70.35
Support Level $269.08 $33.78
Resistance Level $285.54 $38.14
Average True Range (ATR) 7.15 1.20
MACD 1.29 0.56
Stochastic Oscillator 82.62 90.55

Price Performance

Historical Comparison
WST
GFS

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 13,000 people.

Share on Social Networks: